These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 29339043)
1. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy. Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043 [TBL] [Abstract][Full Text] [Related]
2. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy. Chen L; Ma X; Li H; Gu L; Li X; Gao Y; Xie Y; Zhang X PLoS One; 2017; 12(3):e0173953. PubMed ID: 28288191 [TBL] [Abstract][Full Text] [Related]
3. Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy. Życzkowski M; Kaletka Z; Rajwa P; Rempega G; Stelmach P; Bogacki R; Łach-Wojnarowicz O; Paradysz E Int Urol Nephrol; 2020 May; 52(5):885-891. PubMed ID: 31953718 [TBL] [Abstract][Full Text] [Related]
4. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival. Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642 [TBL] [Abstract][Full Text] [Related]
5. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
6. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma. Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study. Ni J; Yao X; Song W; Zhang H; Zhang H; Wang Y; Zhang Y; Wang G; Wang K; Mao W; Peng B Cancer Med; 2024 May; 13(9):e7214. PubMed ID: 38686610 [TBL] [Abstract][Full Text] [Related]
10. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma. Choi JY; Ko YH; Song PH Investig Clin Urol; 2016 Sep; 57(5):324-9. PubMed ID: 27617313 [TBL] [Abstract][Full Text] [Related]
12. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review. Kovac E; Firoozbakhsh F; Zargar H; Fergany A; Elsharkawy H Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354 [TBL] [Abstract][Full Text] [Related]
13. Preoperative Neutrophil-lymphocyte Ratio as a Predictor of Overall Survival in Patients with Localized Renal Cell Carcinoma. Widz D; Mitura P; Buraczynski P; Plaza P; Bar M; Cabanek M; Nowak G; Ostrowska A; Bar K Urol J; 2020 Jan; 17(1):30-35. PubMed ID: 31087321 [TBL] [Abstract][Full Text] [Related]
14. Analysis of long-term survival in patients with localized renal cell carcinoma: laparoscopic versus open radical nephrectomy. Luo JH; Zhou FJ; Xie D; Zhang ZL; Liao B; Zhao HW; Dai YP; Chen LW; Chen W World J Urol; 2010 Jun; 28(3):289-93. PubMed ID: 19916010 [TBL] [Abstract][Full Text] [Related]
15. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360 [TBL] [Abstract][Full Text] [Related]
17. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012. Zhang Y; Yu H; Li H Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269 [TBL] [Abstract][Full Text] [Related]
18. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice. Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448 [TBL] [Abstract][Full Text] [Related]
19. Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma. Zhang ZL; Li YH; Xiong YH; Hou GL; Yao K; Dong P; Liu ZW; Han H; Qin ZK; Zhou FJ Chin J Cancer; 2010 Dec; 29(12):995-9. PubMed ID: 21114919 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of red cell distribution width in esophageal squamous cell carcinoma. Hirahara N; Tajima Y; Fujii Y; Hyakudomi R; Yamamoto T; Ishitobi K; Taniura T; Kawabata Y J Surg Res; 2018 Oct; 230():53-60. PubMed ID: 30100040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]